[An adult case of bacterial meningitis caused by penicillin-resistant Streptococcus pneumoniae]. 1995

M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
Department of Neurology, Tokyo Medical and Dental University.

Recently the incidence of infectious diseases caused by penicillin-resistant Streptococcus pneumoniae (PRSP) is increasing. Patients with meningitis caused by PRSP have been reported with high mortality especially in the field of pediatrics, and it is crucial to treat with accurate and precise choice of antibiotics. We report the first adult case of bacterial meningitis caused by PRSP in Japan. A 32-year-old male without immunological abnormalities developed acute pneumococcal meningitis. Empiric therapy with ampicillin and cefotaxime was not effective and the S. pneumonia from CSF showed resistance to multiple antibiotics such as penicillin and cefotaxime. He was treated successfully with the combination of panipenem/betamipron, vancomycin, and chloramphenicol. We assume that panipenem/betamipron is recommended to be added to empiric therapy of bacterial meningitis, considering an increasing incidence of PRSP infection.

UI MeSH Term Description Entries
D008297 Male Males
D008586 Meningitis, Pneumococcal An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111) Meningitis, Streptococcus pneumoniae,Experimental Pneumococcal Meningitis,Meningitis, Pneumococcal, Experimental,Meningitis, Pneumococcal, Penicillin-Resistant,Meningitis, Pneumococcal, Recurrent,Experimental Pneumococcal Meningitides,Meningitides, Streptococcus pneumoniae,Meningitis, Experimental Pneumococcal,Pneumococcal Meningitides,Pneumococcal Meningitides, Experimental,Pneumococcal Meningitis,Pneumococcal Meningitis, Experimental,Streptococcus pneumoniae Meningitides,Streptococcus pneumoniae Meningitis
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus

Related Publications

M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
March 2004, Rinsho shinkeigaku = Clinical neurology,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
August 1997, Rinsho shinkeigaku = Clinical neurology,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
August 1990, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
October 1995, Antimicrobial agents and chemotherapy,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
March 1996, Antimicrobial agents and chemotherapy,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
November 1988, The Medical journal of Australia,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
November 1993, Presse medicale (Paris, France : 1983),
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
January 1999, Salud publica de Mexico,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
November 1989, Revista clinica espanola,
M Yamawaki, and J Shiraishi, and N Sanjo, and M Michikawa, and Y Wada
February 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Copied contents to your clipboard!